Physician Responses to the Malpractice Crisis: From Defense to Offense

2005 ◽  
Vol 33 (3) ◽  
pp. 416-428 ◽  
Author(s):  
Allen Kachalia ◽  
Niteesh K. Choudhry ◽  
David M. Studdert

Medical science brings innovations in patient care at an astounding pace today - new chemotherapeutic agents, coated stents, and minimally invasive surgery are just few recent examples. For physicians, though, the specter of malpractice liability can overshadow the marvel of practicing in this era. Many physicians are working in a volatile liability environment; they face spiraling costs for malpractice insurance, have difficulties purchasing liability coverage at any price, and see record payouts in a growing number of claims against their colleagues. The American Medical Association (AMA) has declared that at least 20 states are currently in a malpractice “crisis,” with another 24 states showing early signs of an impending crisis.There have been two comparable periods of instability in the last thirty years, but these predecessor crises differ from the current one in important ways. First, while physicians mainly experienced dwindling options for obtaining coverage in the mid-1970s (i.e., availability) and exorbitant prices in the mid-1980s (i.e., affordability), the current crisis appears to have elements of both availability and affordability.

2016 ◽  
Vol 49 (4) ◽  
pp. 577-600 ◽  
Author(s):  
JOSEPH M. GABRIEL

AbstractThe attitudes of physicians and drug manufacturers in the US toward patenting pharmaceuticals changed dramatically from the mid-nineteenth century to the mid-twentieth. Formerly, physicians and reputable manufacturers argued that pharmaceutical patents prioritized profit over the advancement of medical science. Reputable manufactures refused to patent their goods and most physicians shunned patented products. However, moving into the early twentieth century, physicians and drug manufacturers grew increasingly comfortable with the idea of pharmaceutical patents. In 1912, for example, the American Medical Association dropped the prohibition on physicians holding medical patents. Shifts in wider patenting cultures therefore transformed the ethical sensibilities of physicians.


2011 ◽  
Vol 45 (2) ◽  
pp. 192-198
Author(s):  
Shafique N. Virani

Academics who concentrate on the study of Islam live in challenging times. The proliferation of “popular” sources of news and information evokes both significant concern as well as tremendous possibility. This is true across the academy, not only in our own field. In a recent issue of the Journal of the American Medical Association, a team of medical scientists analyzed 153 videos about vaccination and immunization on YouTube. What they found was very disturbing. A staggering number of YouTube videos portrayed vaccinations in a negative light, and about half contained messages completely contradicting established medical science. Furthermore, the research team found that videos with negative portrayals of vaccinations were highly provocative and powerful, and received more views and better ratings by YouTube users than those videos that portray vaccinations in a positive light. The study concludes that this situation is extremely dangerous and that public health officials must consider how to effectively communicate their scientifically founded viewpoints through internet video portals.


PEDIATRICS ◽  
1967 ◽  
Vol 39 (1) ◽  
pp. 150-151
Author(s):  
JOSEPH STOKES

There would appear to be few more difficult assignments in historical review than that of covering the multitude of items in the field of medical science—and what was mostly not science—with which the American Pediatric Society was concerned during its growth and development. When one remembers that, at the time of its birth in 1888, such procreators as its first president, Abraham Jacobi (who also became President of the American Medical Association), William Osler, Job Lewis Smith, Luther Emmett Holt, William Pepper, Victor C. Vaughan, and Henry Dwight Chapin were just beginning to accept the revolution of Louis Pasteur and Lister, one can well imagine the authors' problem of unfolding, in adequate sequence, the rapidly developing panorama of pediatric medicine.


Author(s):  
W. Allen Shannon ◽  
José A. Serrano ◽  
Hannah L. Wasserkrug ◽  
Anna A. Serrano ◽  
Arnold M. Seligman

During the design and synthesis of new chemotherapeutic agents for prostatic carcinoma based on phosphorylated agents which might be enzyme-activated to cytotoxicity, phosphorylcholine, [(CH3)3+NCH2CH2OPO3Ca]Cl-, has been indicated to be a very specific substrate for prostatic acid phosphatase (PAP). This phenomenon has led to the development of specific histochemical and ultracytochemical methods for PAP using modifications of the Gomori lead method for acid phosphatase. Comparative histochemical results in prostate and kidney of the rat have been published earlier with phosphorylcholine (PC) and β-glycerophosphate (βGP). We now report the ultracytochemical results.Minced tissues were fixed in 3% glutaraldehyde-0.1 M phosphate buffered (pH 7.4) for 1.5 hr and rinsed overnight in several changes of 0.05 M phosphate buffer (pH 7.0) containing 7.5% sucrose. Tissues were incubated 30 min to 2 hr in Gomori acid phosphatase medium (2) containing 0.1 M substrate, either PC or βGP.


2004 ◽  
Vol 171 (4S) ◽  
pp. 448-448
Author(s):  
Farjaad M. Siddiq ◽  
Patrick Villicana ◽  
Raymond J. Leveillee

Sign in / Sign up

Export Citation Format

Share Document